Patent details

EP1842535 Title: Use of agomelatine to obtain a medication aimed at treating generalised anxiety disorder

Basic Information

Publication number:
EP1842535
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP072904204
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
French
English Title of Invention:
Use of agomelatine to obtain a medication aimed at treating generalised anxiety disorder
French Title of Invention:
Utilisation de l'agomélatine pour l'obtention de médicaments destinés au traitement du Trouble Anxiété Généralisée
German Title of Invention:
Verwendung von Agomelatin zur Herstellung von Medikamenten zur Behandlung der generalisierten Angststörung
SPC Number:

Dates

Filing date:
06/04/2007
Grant date:
18/08/2010
EP Publication Date:
18/08/2010
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/10/2007
EP B1 Publication Date:
18/08/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
06/04/2027
Renunciation date:
Revocation date:
23/02/2019
Annulment date:

Owner

From:
06/04/2007
 
 

Name:
Les Laboratoires Servier
Address:
12, Place de La Défense, 92415 Courbevoie Cedex, France (FR)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
08/09/2010
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Fabiano Agnès
Address:
France (FR)

2

Name:
Mocaer Elisabeth
Address:
France (FR)

3

Name:
Delalleau Bruno
Address:
France (FR)

4

Name:
Millan Mark
Address:
France (FR)

Priority

Priority Number:
0603083
Priority Date:
07/04/2006
Priority Country:
France (FR)

Classification

Main IPC Class:
A61K 31/165;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2019/05
Publication date:
11/04/2019
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

Issue number:
201914
Publication date:
03/04/2019
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
08/03/2018
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages